RAPT Therapeutics to Participate in Upcoming Investor Conferences
Rhea-AI Summary
RAPT Therapeutics (Nasdaq: RAPT), a clinical-stage biopharmaceutical company specializing in immunology-based therapies, has announced its participation in two major investor conferences in March 2025. The company, which focuses on developing treatments for inflammatory and immunological diseases, will be featured in:
- The Leerink Global Healthcare Conference with a fireside chat scheduled for March 11, 2025 at 3:40 p.m. ET
- The Barclays 27th Annual Global Healthcare Conference with a fireside chat planned for March 12, 2025 at 10:30 a.m. ET
Interested parties can access live webcasts and archived recordings of these discussions through the company's investor relations website at investors.rapt.com/events-and-presentations.
Positive
- None.
Negative
- None.
SOUTH SAN FRANCISCO, Calif., March 07, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced that members of the RAPT management team will participate in the following investor conferences in March:
- Leerink Global Healthcare Conference – Fireside chat on Tuesday, March 11, 2025 at 3:40 p.m. ET
- Barclays 27th Annual Global Healthcare Conference – Fireside chat on Wednesday, March 12, 2025 at 10:30 a.m. ET
To access the live webcasts or subsequent archived recordings of the discussions, please visit the RAPT Therapeutics website at https://investors.rapt.com/events-and-presentations.
About RAPT Therapeutics, Inc.
RAPT Therapeutics is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases. Utilizing our deep and proprietary expertise in immunology, we develop novel therapies that are designed to modulate the critical immune responses underlying these diseases.
RAPT Investor Contact:
Sylvia Wheeler
swheeler@wheelhouselsa.com
RAPT Media Contact:
Aljanae Reynolds
areynolds@wheelhouselsa.com
FAQ
When is RAPT Therapeutics presenting at the Leerink Global Healthcare Conference in March 2025?
What type of conferences will RAPT Therapeutics attend in March 2025?
How can investors access RAPT Therapeutics' conference presentations?
What is RAPT Therapeutics' current development focus in 2025?
